However, it is not known whether the CUL5 E3 ligase complexes regulate CD8+ T cell activation or function through any of these CIS/SOCS family proteins in CD8+ T cells despite CUL5 regulates phosphorylated JAK1 degradation by interacting with CISH in CD4 cells41. The gene discussed is CISH; the disease is in situ carcinoma.